Adaptimmune Therapeutics PLC (ADAPY) › Cost of RevenueAdaptimmune Therapeutics PLC (ADAPY) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.Fiscal YearCost of RevenueChange YoY2024$70.0K—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share